GlassScriptPhysician profile
Gregg Shore
NPI 1235138983
$28,688.36
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $6,957 · 2021: $3,648 · 2022: $159 · 2023: $75.06 · 2024: $55.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $26,202.08 | 2019-2021 | |
| Davol INC. | $922.56 | 2019-2020 | |
| Medtronic USA, INC. | $253.70 | 2019-2020 | |
| Aesculap, INC. | $158.49 | 2019-2020 | |
| Kerecis Limited | $158.13 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| C. R. Bard, INC. & Subsidiaries | $134.14 | 2019 | |
| Medtronic, INC. | $108.89 | 2021-2024 | Closurefast |
| Smith+Nephew, INC. | $84.40 | 2020-2022 | |
| Medtronic Vascular, INC. | $75.81 | 2020 | |
| Tela Bio, INC. | $68.90 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $67.22 | 2019-2020 | |
| Endogastric Solutions, INC | $63.99 | 2021 | |
| Kci USA, INC. | $56.87 | 2019-2021 | |
| Ethicon US, LLC | $55.16 | 2020-2022 | |
| Angiodynamics, INC. | $43.63 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36.08 | 2021-2022 | |
| Acera Surgical, INC. | $21.67 | 2023 | Restrata Wound Matrix |
| Cashflow Solutions, LLC | $18.82 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Covidien LP | $18.74 | 2019 | |
| Shire North American Group INC | $16.83 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.61 | 2021 | |
| Axonics, INC. | $16.47 | 2021 | |
| Musculoskeletal Transplant Foundation INC. | $16.02 | 2021 | |
| Boston Scientific Corporation | $15.70 | 2022 | |
| Olympus America INC. | $15.31 | 2021 | |
| Convatec INC. | $14.88 | 2023 | |
| Ge Healthcare | $14.54 | 2019 | |
| Lemaitre Vascular, INC. | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregg Shore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.